Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma Meeting Abstract
| Authors: | Jameson-Lee, M.; Ott, P. A.; Luke, J. J.; Postow, M. A.; Poklepovic, A. S. |
| Abstract Title: | Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120307062 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS9596 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS9596 -- Source: Wos |
